Dimerix

Dimerix is a clinical stage drug discovery and development company. The operational headquarters of the company are in Melbourne, where Dimerix’s lead clinical program is a Phase 2 study in Chronic Kidney Disease, DMX-200. This study has repurposing of existing molecules at its core, and upon successful results from this study, Dimerix Bioscience was established as a private company in 2004, based on technology developed at the University of Western Australia, known as Receptor-Heteromer Investigation Technology (HIT)

Dimerix Bioscience underwent conversion to a public unlisted company in June 2014 and in July 2015 became a wholly owned subsidiary of Sun Biomedical Limited through a reverse takeover. Sun Biomedical’s name was changed to Dimerix Limited in November 2015.

Contact Details

Suite 5, 95 Hay Street , SUBIACO WA 6008

0409 050 519

info@dimerix.com

www.dimerix.com

Lists and Charts

Share price

Dimerix
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
75^th	SciDev	160.75%	1.46%
76^th	Home Consortium	159.84%	31.52%
77^th	Dimerix	159.6%	22.39%
78^th	Adisyn	156.58%	0%
79^th	Paragon Care	154.9%	3.78%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	NEWS: Tagged in Sparc fires up following three-way hydrogen tie-in	10 Jan 2025
	NEW ROLE: David Fuller,	04 Oct 2024
	NEW ROLE: Robert Shepherd,	04 Oct 2024
	NEW ROLE: Clinton Snow, Non-Executive Director	25 Jul 2024
	NEW ROLE: Mark Diamond, Non-Executive Director	25 Jul 2024
	NEWS: Tagged in Biotech company inks $230m deal	05 Oct 2023
	NEWS: Tagged in Promise of new era in venture capital	29 Mar 2023

Sponsored Content

Thursday, 28 November, 2013 - 11:52
Biotech sector haunted by 'valley of death'
FEATURE: The state’s biotechnology sector is heating up as investors look for the next wave of investment opportunities amid waning resources investment.
Monday, 7 July, 2014 - 10:51
Market awaits strong lead
FEATURE: The June quarter presented a broad range of transactions for corporate players, however a noticeable lack of direction remains.
Wednesday, 13 May, 2015 - 11:51
Sun Biomedical buys Melbourne firm for $8.3m
Local biotech firm Sun Biomedical has announced plans to buy Melbourne-based Dimerix Bioscience in exchange for a share package worth about $8.3 million.
Monday, 26 October, 2015 - 09:43
Puzzle over FMG share holdings
Fortescue Metals Group is home to two of Western Australia’s wealthiest company directors, or so it was believed until a surprise disclosure last month.
Thursday, 9 March, 2017 - 14:48
Pfleger taking medical research out of the lab
40under40: Kevin Pfleger is on a mission to turn WA medical research into solutions for chronic disease.
Tuesday, 1 August, 2017 - 17:13
Board Moves August 1, 2017
Nicholas Clark has retired as executive director, strategy at Alexium International Group to focus on his young family in the US following the unexpected loss of his wife last year. Mr Clark will also be stepping down from all public and community roles.
Monday, 26 February, 2018 - 17:04
Corporate finance deals Feb 19 to Feb 23 2018
Black Mountain Resources Limited is pleased to update shareholders on the following restructure initiatives that have been agreed to by the Company and its major lender, Richmond Partners Masters Limited, subject to any necessary shareholder approvals, formal documentation and regulatory sign off
Monday, 27 August, 2018 - 18:55
Board Moves August 27, 2018
Experienced biotech and pharmaceuticals professional, Dr Nina Webster, has been appointed chief executive and managing director of Dimerix.
Loading
Wednesday, 19 December, 2018 - 10:03
Proteomics kit fit for market
It has taken over 15 years, but Perth-based medical technology company Proteomics International is now launching a commercial product targeted at the US.
Loading
Monday, 16 August, 2021 - 11:00
Dimerix raises $20m, shares surge
Peter Meurs and Perth-based Merchant Group have invested $9.5 million in biopharmaceutical company Dimerix, as part of a broader capital raising to fast-track clinical studies.
Loading
Friday, 15 October, 2021 - 14:00
Dimerix starts COVID-19 drug trials
Perth-founded biopharmaceutical business Dimerix has launched phase three drug trials for patients with COVID-19 and kidney diseases.
Loading
Wednesday, 29 March, 2023 - 15:48
Promise of new era in venture capital
Three new local funds proposing to focus on early-stage investment are raising expectations.
Loading Image
Thursday, 5 October, 2023 - 15:27
Biotech company inks $230m deal
There's a Perth connection to a deal struck by pharmaceutical company Dimerix with UK-based Advanz Pharma worth up to $230 million.

Market awaits strong lead
Monday, 7 July, 2014 - 10:51

Promise of new era in venture capital
Wednesday, 29 March, 2023 - 15:48
TimelineJS
Biotech sector haunted by 'valley of death'
Market awaits strong lead
Sun Biomedical buys Melbourne firm for $8.3m
Puzzle over FMG share holdings
Pfleger taking medical research out of the lab
Board Moves August 1, 2017
Corporate finance deals Feb 19 to Feb 23 2018
Board Moves August 27, 2018
Proteomics kit fit for market
Dimerix raises $20m, shares surge
Dimerix starts COVID-19 drug trials
Promise of new era in venture capital
Biotech company inks $230m deal
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
2052
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
March
April
May
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
News Articles

Loading Image
Tuesday, 12 June, 2018 - 14:58
Commercialising medical research
Australia’s medical technology, biotechnology and pharmaceutical sector is showing encouraging signs for future investors.

Next
Date

Previous
Date
TimelineJS
Commercialising medical research
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Jan.
March
April
May
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Oct.
Nov.
Dec.
Jan.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
March 13
March 14
March 15
March 16
March 17
March 18
March 19
March 20
March 21
March 22
March 23
March 24
March 25
March 26
March 27
March 28
March 29
March 30
March 31
April 2
April 3
April 4
April 5
April 6
April 7
April 8
April 9
April 10
April 11
April 12
April 13
April 14
April 15
April 16
April 17
April 18
April 19
April 20
April 21
April 22
April 23
April 24
April 25
April 26
April 27
April 28
April 29
April 30
May 2
May 3
May 4
May 5
May 6
May 7
May 8
May 9
May 10
May 11
May 12
May 13
May 14
May 15
May 16
May 17
May 18
May 19
May 20
May 21
May 22
May 23
May 24
May 25
May 26
May 27
May 28
May 29
May 30
May 31
June 2
June 3
June 4
June 5
June 6
June 7
June 8
June 9
June 10
June 11
June 12
June 13
June 14
June 15
June 16
June 17
June 18
June 19
June 20
June 21
June 22
June 23
June 24
June 25
June 26
June 27
June 28
June 29
June 30
July 2
July 3
July 4
July 5
July 6
July 7
July 8
July 9
July 10
July 11
July 12
July 13
July 14
July 15
July 16
July 17
July 18
July 19
July 20
July 21
July 22
July 23
July 24
July 25
July 26
July 27
July 28
July 29
July 30
July 31
Aug. 2
Aug. 3
Aug. 4
Aug. 5
Aug. 6
Aug. 7
Aug. 8
Aug. 9
Aug. 10
Aug. 11
Aug. 12
Aug. 13
Aug. 14
Aug. 15
Aug. 16
Aug. 17
Aug. 18
Aug. 19
Aug. 20
Aug. 21
Aug. 22
Aug. 23
Aug. 24
Aug. 25
Aug. 26
Aug. 27
Aug. 28
Aug. 29
Aug. 30
Aug. 31
Sept. 2
Sept. 3
Sept. 4
Sept. 5
Sept. 6
Sept. 7
Sept. 8
Sept. 9
Sept. 10
Sept. 11

Related Information

Access to our data for Dimerix is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Dimerix is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today

Dimerix

Contact Details